Debevoise Advises The Evercare Group in its $72 million Sale of a 50% Stake in Islamabad Diagnostic Centre

22 December 2021

Debevoise & Plimpton LLP has advised the Evercare Group in the signing of a $72.35 million sale purchase agreement to sell a 50% shareholding in Base Consultancy FZ LLC, the holding company of Islamabad Diagnostic Centre (Private) Limited (“IDC"), to leading consumer healthcare company Integrated Diagnostics Holdings (“IDH”).

The transaction will see IDH acquire a stake in one of Pakistan's leading diagnostic providers, and partner with the founder Dr. Rizwan Uppal. It is expected to close in the first half of 2022.

The Evercare Group is an emerging markets healthcare delivery platform managed by TPG and backed by The Rise Fund.

For full details, see the official release here.

The Debevoise team advising the Evercare Group is being led by partner Geoffrey Burgess, and includes associates David Becker and Hilary Davidson. Competition advice is being provided by partner Timothy McIver and associate Megan MacDonald.